INVION SECURES RESEARCH ALLIANCE WITH HUDSON INSTITUTE OF MEDICAL RESEARCH ― Hudson Institute is a leading Australian biomedical research institute recognised internationally for delivering better health through research into cancer and inflammation
― The alliance is aimed at advancing Invion’s licenced cancer treatment technology,
PhotosoftTM
― Hudson Institute will provide research and clinical expertise on a series of projects in collaboration with Invion
― Projects will target a range of common and difficult to treat cancers, starting with ovarian cancer ― Invion’s development costs are financed by a non-dilutive funding agreement with The Cho Group
IVX Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)